DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:CPR - NL0015435975 - Common Stock
5.866 EUR
+0.05 (+0.86%)
Overall CPR gets a fundamental rating of 4 out of 10. We evaluated CPR against 27 industry peers in the Beverages industry. CPR has only an average score on both its financial health and profitability. While showing a medium growth rate, CPR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year CPR was profitable.
In the past year CPR had a positive cash flow from operations.
CPR had positive earnings in each of the past 5 years.
CPR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CPR's Return On Assets of 2.51% is on the low side compared to the rest of the industry. CPR is outperformed by 62.96% of its industry peers.
CPR has a Return On Equity of 5.44%. This is in the lower half of the industry: CPR underperforms 70.37% of its industry peers.
CPR has a Return On Invested Capital of 7.03%. This is comparable to the rest of the industry: CPR outperforms 59.26% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 7.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROIC | 7.03% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
With a Profit Margin value of 6.57%, CPR perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
In the last couple of years the Profit Margin of CPR has declined.
With a Operating Margin value of 21.32%, CPR perfoms like the industry average, outperforming 59.26% of the companies in the same industry.
CPR's Operating Margin has been stable in the last couple of years.
CPR's Gross Margin of 57.55% is fine compared to the rest of the industry. CPR outperforms 74.07% of its industry peers.
CPR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
Compared to 1 year ago, CPR has more shares outstanding
Compared to 5 years ago, CPR has more shares outstanding
CPR has about the same debt/assets ratio as last year.
2.2 Solvency
An Altman-Z score of 2.57 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
CPR has a Altman-Z score of 2.57. This is in the better half of the industry: CPR outperforms 74.07% of its industry peers.
The Debt to FCF ratio of CPR is 8.49, which is on the high side as it means it would take CPR, 8.49 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.49, CPR is in line with its industry, outperforming 51.85% of the companies in the same industry.
CPR has a Debt/Equity ratio of 0.64. This is a neutral value indicating CPR is somewhat dependend on debt financing.
CPR's Debt to Equity ratio of 0.64 is fine compared to the rest of the industry. CPR outperforms 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Altman-Z | 2.57 |
ROIC/WACC1.06
WACC6.66%
2.3 Liquidity
CPR has a Current Ratio of 2.32. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
CPR has a better Current ratio (2.32) than 85.19% of its industry peers.
A Quick Ratio of 0.91 indicates that CPR may have some problems paying its short term obligations.
CPR has a better Quick ratio (0.91) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The earnings per share for CPR have decreased strongly by -40.50% in the last year.
Measured over the past years, CPR shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.12% on average per year.
The Revenue has been growing slightly by 5.18% in the past year.
CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.75% yearly.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
3.2 Future
The Earnings Per Share is expected to grow by 11.73% on average over the next years. This is quite good.
CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.72% yearly.
EPS Next Y0.81%
EPS Next 2Y4.38%
EPS Next 3Y6.89%
EPS Next 5Y11.73%
Revenue Next Year1.7%
Revenue Next 2Y2.14%
Revenue Next 3Y3.2%
Revenue Next 5Y4.72%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CPR is valuated quite expensively with a Price/Earnings ratio of 34.51.
77.78% of the companies in the same industry are cheaper than CPR, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.15. CPR is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 18.14, which indicates a rather expensive current valuation of CPR.
CPR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CPR is more expensive than 62.96% of the companies in the same industry.
CPR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.51 | ||
| Fwd PE | 18.14 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CPR is valued a bit more expensive than 62.96% of the companies in the same industry.
CPR's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.51 | ||
| EV/EBITDA | 11.76 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)42.62
PEG (5Y)N/A
EPS Next 2Y4.38%
EPS Next 3Y6.89%
5. Dividend
5.1 Amount
CPR has a Yearly Dividend Yield of 1.21%.
CPR's Dividend Yield is slightly below the industry average, which is at 3.07.
With a Dividend Yield of 1.21, CPR pays less dividend than the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.21% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CPR pays out 38.69% of its income as dividend. This is a sustainable payout ratio.
DP38.69%
EPS Next 2Y4.38%
EPS Next 3Y6.89%
BIT:CPR (11/28/2025, 5:36:15 PM)
5.866
+0.05 (+0.86%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners22.94%
Inst Owner ChangeN/A
Ins Owners51.06%
Ins Owner ChangeN/A
Market Cap7.22B
Revenue(TTM)3.07B
Net Income(TTM)201.60M
Analysts71.54
Price Target6.91 (17.8%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.21% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.25%
PT rev (3m)-1.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.57%
EPS NY rev (3m)1.4%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)-1.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.51 | ||
| Fwd PE | 18.14 | ||
| P/S | 2.35 | ||
| P/FCF | 22.51 | ||
| P/OCF | 11.07 | ||
| P/B | 1.95 | ||
| P/tB | 59.49 | ||
| EV/EBITDA | 11.76 |
EPS(TTM)0.17
EY2.9%
EPS(NY)0.32
Fwd EY5.51%
FCF(TTM)0.26
FCFY4.44%
OCF(TTM)0.53
OCFY9.03%
SpS2.49
BVpS3.01
TBVpS0.1
PEG (NY)42.62
PEG (5Y)N/A
Graham Number3.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROCE | 9.58% | ||
| ROIC | 7.03% | ||
| ROICexc | 7.57% | ||
| ROICexgc | 17.42% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 10.45% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexgc growth 3Y-20.45%
ROICexgc growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | 230.39% | ||
| Cap/Sales | 10.79% | ||
| Interest Coverage | 6.41 | ||
| Cash Conversion | 81.69% | ||
| Profit Quality | 159.18% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.57 |
F-Score6
WACC6.66%
ROIC/WACC1.06
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
EPS Next Y0.81%
EPS Next 2Y4.38%
EPS Next 3Y6.89%
EPS Next 5Y11.73%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
Revenue Next Year1.7%
Revenue Next 2Y2.14%
Revenue Next 3Y3.2%
Revenue Next 5Y4.72%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year24.36%
EBIT Next 3Y12.31%
EBIT Next 5Y10.3%
FCF growth 1Y290.11%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y205.34%
OCF growth 3Y11.5%
OCF growth 5Y13.06%
DAVIDE CAMPARI-MILANO NV / CPR.MI FAQ
Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?
ChartMill assigns a fundamental rating of 4 / 10 to CPR.MI.
What is the valuation status of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.
What is the profitability of CPR stock?
DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 4 / 10.
What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?
The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 34.51 and the Price/Book (PB) ratio is 1.95.
How sustainable is the dividend of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
The dividend rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 2 / 10 and the dividend payout ratio is 38.69%.